Opinion: As More Companies Are Targeted by BIOSECURE Act, Investor Relations Crisis Brews

The House Select Committee asks the FBI for a briefing on GenScript’s links to China, fueling the challenge facing public relations and investor relations teams at US biopharma firms and Chinese CDMOs.

Scroll to Top